DAIC

FEBRUARY 13, 2024

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Barcelona, Spain. 4 Chiou A, Hermel M, Miller G et al.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia 110

Ischemia Atherosclerosis Chest Pain Coronary Artery Disease 110

DAIC

JANUARY 17, 2024

Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e016138, January 1, 2024. BACKGROUND:Guidelines propose the inclusion of quantitative measurements from82Rubidium positron emission tomography (RbPET) to discriminate obstructive coronary artery disease (CAD).

Coronary Artery Disease 40

Coronary Artery Disease Stenosis Cardiovascular Imaging Circulation 40